switching from semaglutide to tirzepatide washout period between weight-loss medications Switching from tirzepatide to semaglutide

Perez-Aso M, Montesinos MC, Mediero A, Wilder T, Schafer PH, Cronstein B (2015) Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors

[DOI] [PubMed] [Google Scholar] Perper M., Eber A.E., Fayne R., Verne S.H., Magno R.J., Cervantes J

Notably, SURMOUNT-1, which excluded patients with diabetes, showed improvements with tirzepatide in all prespecified cardiometabolic measures

Now with modern technology we can harness those anti-inflammatory effects to provide long term benefits, whether thats a reduction in psoriasis symptoms, decreased risk of cardiovascular disease, possibly less risk of dying from infection and who knows what else

Severe or Allergic Reactions Severe allergic reactions to tirzepatide are rare, but they can occur